课题基金 / 基金详情

Bacterial and Molecular Determinants of Mycobacterial Impermeability

Bacterial and Molecular Determinants of Mycobacterial Impermeability
分枝杆菌不渗透性的细菌和分子决定因素
批准号:
10749613
负责人:
Marcos M. Pires
金额:
$74.19万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2023
资助国家:
美国
项目状态:
未结题
起止时间:
2023-08-02 至 2028-07-31

项目摘要

项目成果

Marcos M. Pires的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Project Summary The typical course of treatment for uncomplicated Mycobacterium tuberculosis infection comprises four antibiotics and lasts for at least six months. The impermeability of the multi-layered M. tuberculosis cell envelope has long been linked to the organism’s intrinsically-poor drug susceptibility. While the outer ‘myco’ membrane is hypothesized to be the primary barrier to accessing antibiotic targets in the peptidoglycan or cytoplasm, other facets of the envelope likely contribute. Moreover, compared to the model organism Escherichia coli and to mammalian cells, the field has only a rudimentary understanding of the kinds of compounds that can permeate M. tuberculosis. Based on published and preliminary data, the PIs hypothesize that M. tuberculosis impermeability is a consequence of envelope composition as well as the target location and chemical structure of the compound. A major hurdle to testing this hypothesis is the lack of high-throughput tools for identifying bacterial and molecular factors that control compound permeation across envelope layers. In this proposal, The PIs develop and deploy two complementary methods for defining the bacterial and molecular determinants of M. tuberculosis impermeability. They will first test the relative importance of various M. tuberculosis factors in molecule gate-keeping. Next, they will globally determine the M. tuberculosis genes that contribute to mycomembrane impermeability. Finally, they will comprehensively determine the structural motifs associated with M. tuberculosis mycomembrane permeation or lack thereof. Successful completion of these aims will lay the foundation for medicinal chemistry efforts to improve M. tuberculosis uptake of both existing drugs and newly-discovered compounds. The methods that the PIs use to achieve these aims are easily ported to species for which envelope permeability is also treatment-limiting, e.g., non-tuberculous mycobacteria (NTMs) and Gram-negatives.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Structural Determinants of Permeation Barriers in Escherichia coli
  • 批准号:
    10749251
  • 项目类别:
  • 资助金额:
    $62.32万
  • 财政年份:
    2023
  • 负责人:
    Marcos M. Pires
  • 依托单位:
Chemical Remodeling of Cell Surface to Enhance the Accumulation of Therapeutic Bacteria to Tumors
  • 批准号:
    10535464
  • 项目类别:
  • 资助金额:
    $21.38万
  • 财政年份:
    2022
  • 负责人:
    Marcos M. Pires
  • 依托单位:
Chemical Remodeling of Cell Surface to Enhance the Accumulation of Therapeutic Bacteria to Tumors
  • 批准号:
    10391986
  • 项目类别:
  • 资助金额:
    $19.75万
  • 财政年份:
    2022
  • 负责人:
    Marcos M. Pires
  • 依托单位:
Unraveling Bacterial Cell Wall Biosynthesis and Sensing via Synthetic Analogs
  • 批准号:
    10381814
  • 项目类别:
  • 资助金额:
    $8.67万
  • 财政年份:
    2017
  • 负责人:
    Marcos M. Pires
  • 依托单位:
海外基金